Ginkgo Bioworks Holdings, Inc. (DNA) key performance indicators and operating metrics (4 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Biosecurity Revenue | 10M | FY2025-Q2 |
| Cell Engineering Revenue Excluding Non-Cash Deferred Revenue Release Impact | 39M | FY2025-Q2 |
| Biosecurity Gross Profit Margin | 17.00 percent | FY2024-Q4 |
| New Programs and Other Customer Contracts Added | 31.00 | FY2024-Q4 |
Back to DNA overview · DNA earnings · DNA holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.